BX · News · 20261107N
VITALYST Development Co-Funding
Blackstone Inc. · 2026-11-07 · Importance null · Surprise null · In source text
Blackstone Life Sciences has agreed to provide Boston Scientific with up to US$455 million to co-fund development of its VITALYST heart pump. The reported financing supports development of the medical device, with funding described as an amount of up to US$455 million. The report does not specify a funding timetable or further terms.
Key facts
- Blackstone Life Sciences is providing up to US$455 million to co-fund development of Boston Scientific's VITALYST heart pump. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -0.4% | Blackstone Life Sciences is providing up to US$455 million to co-fund development of Boston Scientific's VITALYST heart pump. |